Oral Answers to Questions

Esther McVey Excerpts

Tuesday 7th March 2023 Commons Chamber

[Maria Caulfield]

It is a shame that, on International Women’s Day, the shadow Minister cannot welcome the progress we are making on the menopause. Labour could have done this. We are the first Government to reduce the cost of HRT for women. [Interruption.] The shadow Secretary of State, the hon. Member for Ilford North (Wes Streeting), wants to listen because this is important for women. All licensed HRT products will be available on the prepayment certificate. On the issue of shortages, over 70 products are available to women. Last year, 19 of them were facing a shortage. Thanks to the work of this Government, that is down to five products, and Utrogestan, a product widely used by women, is now back in stock and is being distributed to pharmacies. We are passionate about making HRT more available. There has been a 50% increase in the number of women getting HRT prescriptions. That is a tremendous success for women and we are reducing the cost.

[Esther McVey (Tatton) (Con)]

14. When he plans to reply to the letter of 24 January from the right hon. Member for Tatton on non-covid excess deaths.

[The Parliamentary Under-Secretary of State for Health and Social Care (Neil O’Brien)]

In my letter to my right hon. Friend, I noted that it is likely that a combination of factors has contributed to potential excess deaths, including high flu prevalence, ongoing covid-19, and the disruption to the treatment and detection of conditions such as heart disease. But I know she is very thoughtful about this and follows it closely, and I will endeavour to get her more details.

[Esther McVey]

I am pleased my question has now resulted in a response, for which I am grateful. However, from that response, I was none the wiser as to how the Government have explained the non-covid excess deaths we have seen. So can the Minister give us an insight into the reasons for the non-covid excess deaths since the pandemic?